Predicting diabetes mellitus metabolic goals and chronic complications transitions—analysis based on natural language processing and machine learning models

Claudia C Colmenares-Mejia, Andres Garcia-Suaza, Paul Rodríguez-Lesmes, Christian Lochmuller, Sara C Atehortúa, Camacho-Cogollo Je, Juan P Martínez, Juliana Rincón, Yohan R Céspedes, Esteban Morales-Mendoza and Mario A Isaza-Ruget
Authors registered in the RePEc Author Service: Paul Andres Rodriguez Lesmes

PLOS ONE, 2025, vol. 20, issue 4, 1-20

Abstract: Objective: To estimate Diabetes mellitus (DM) progression at one and two years in terms of glycemic targets and development of complications. Research design and methods: We analyzed a retrospective cohort of adult DM patients treated in a Health Maintenance Organization in Colombia, including those with at least one glycosylated hemoglobin (HbA1c) measurement in 2018, 2019, and 2020. We defined four disease transition stages based on metabolic goals according to HbA1c levels and complications: 1. Within HbA1c goals and without complications; 2. Outside goals and without complications, 3. Within goals, but with complications, and 4. Outside goals and with complications. We applied Natural Language Processing (NLP) techniques to extract relevant clinical information from Electronic Health Records. Machine learning (ML) models were used to predict patient progression. Results: A total of 23,802 patients were included. Despite achieving initial glycemic control, more than 60% of patients who started within HbA1c targets and without complications developed chronic complications within two years. Our models, which achieved up to 80% accuracy and F1 scores above 74%, identified key predictors of disease progression. Adherence to dyslipidemia treatment guidelines significantly reduced the likelihood of HbA1c deterioration and complications, whereas non-adherence to pharmacological treatments increased the risk of complications. These findings suggest that HbA1c control alone is insufficient to prevent disease progression and that a more comprehensive management approach—including lipid control, kidney function monitoring, and improved adherence to clinical guidelines—is necessary. Conclusions: Patient compliance with pharmacological treatments, professional adherence to clinical practice guidelines, and lifestyle interventions play a crucial role in diabetes progression. While our models provide strong predictive capabilities, improving data quality and integration remains essential for better forecasting and intervention strategies.

Date: 2025
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0321258 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 21258&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0321258

DOI: 10.1371/journal.pone.0321258

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().